Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Ribes

Showing results (31-40 of 93) with videos related to

Pageof 10
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|July 9, 2011
Oxalate nephropathy associated with chronic pancreatitisClaire Cartery, Stanislas Faguer, Alexandre Karras, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|January 24, 2007
Renal function and histology in kidney transplant patients receiving tacrolimus and sirolimus or mycophenolate mofetilNassim Kamar, Tuan Tran Van, David Ribes, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 28, 2005
Questionnaire-based evaluation of gastrointestinal disorders in de novo renal-transplant patients receiving either mycophenolate mofetil or enteric-coated mycophenolate sodiumNassim Kamar, Loubna Oufroukhi, Patrick Faure, et al.
Renal Failure|July 11, 2006
Predictive factors for chronic renal failure one year after orthotopic liver transplantationJoelle Guitard, David Ribes, Nassim Kamar, et al.
Transplantation|December 24, 2005
Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patientsGrégoire Basse, David Ribes, Nassim Kamar, et al.
Journal of Medical Virology|April 23, 2008
Predictive factors for cytomegalovirus reactivation in cytomegalovirus-seropositive kidney-transplant patientsNassim Kamar, Catherine Mengelle, Laure Esposito, et al.
Clinical Immunology (Orlando, Fla.)|June 26, 2017
Alternative complement pathway hemolytic assays reveal incomplete complement blockade in patients treated with eculizumabBénédicte Puissant-Lubrano, Sylvain Puissochet, Nicolas Congy-Jolivet, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|March 22, 2012
Long-term results of conversion from calcineurin inhibitors to sirolimus in 150 maintenance kidney transplant patientsCyril Garrouste, Nassim Kamar, Céline Guilbeau-Frugier, et al.
Kidney International Reports|April 29, 2021
Role of C5 inhibition in Idiopathic Inflammatory Myopathies and Scleroderma Renal Crisis-Induced Thrombotic MicroangiopathiesAnna Gouin, David Ribes, Magali Colombat, et al.
Frontiers in Pharmacology|February 21, 2015
Kinin B1 receptor antagonism is equally efficient as angiotensin receptor 1 antagonism in reducing renal fibrosis in experimental obstructive nephropathy, but is not additiveAntoine Huart, Julie Klein, Julien Gonzalez, et al.
Pageof 10

Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Clinical Journal of the American Society of Nephrology : CJASN|July 9, 2011
Oxalate nephropathy associated with chronic pancreatitisClaire Cartery, Stanislas Faguer, Alexandre Karras, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|January 24, 2007
Renal function and histology in kidney transplant patients receiving tacrolimus and sirolimus or mycophenolate mofetilNassim Kamar, Tuan Tran Van, David Ribes, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 28, 2005
Questionnaire-based evaluation of gastrointestinal disorders in de novo renal-transplant patients receiving either mycophenolate mofetil or enteric-coated mycophenolate sodiumNassim Kamar, Loubna Oufroukhi, Patrick Faure, et al.
Renal Failure|July 11, 2006
Predictive factors for chronic renal failure one year after orthotopic liver transplantationJoelle Guitard, David Ribes, Nassim Kamar, et al.
Transplantation|December 24, 2005
Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patientsGrégoire Basse, David Ribes, Nassim Kamar, et al.
Journal of Medical Virology|April 23, 2008
Predictive factors for cytomegalovirus reactivation in cytomegalovirus-seropositive kidney-transplant patientsNassim Kamar, Catherine Mengelle, Laure Esposito, et al.
Clinical Immunology (Orlando, Fla.)|June 26, 2017
Alternative complement pathway hemolytic assays reveal incomplete complement blockade in patients treated with eculizumabBénédicte Puissant-Lubrano, Sylvain Puissochet, Nicolas Congy-Jolivet, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|March 22, 2012
Long-term results of conversion from calcineurin inhibitors to sirolimus in 150 maintenance kidney transplant patientsCyril Garrouste, Nassim Kamar, Céline Guilbeau-Frugier, et al.
Kidney International Reports|April 29, 2021
Role of C5 inhibition in Idiopathic Inflammatory Myopathies and Scleroderma Renal Crisis-Induced Thrombotic MicroangiopathiesAnna Gouin, David Ribes, Magali Colombat, et al.
Frontiers in Pharmacology|February 21, 2015
Kinin B1 receptor antagonism is equally efficient as angiotensin receptor 1 antagonism in reducing renal fibrosis in experimental obstructive nephropathy, but is not additiveAntoine Huart, Julie Klein, Julien Gonzalez, et al.
Pageof 10